Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending September 30, 2023 was 6.09 (a -14.83% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA decreased by -36.42%
- Annual Net Debt/EBITDA for 2022 was 1.79 (a -52.1% decrease from previous year)
- Annual Net Debt/EBITDA for 2021 was 3.74 (a -26.71% decrease from previous year)
- Annual Net Debt/EBITDA for 2020 was 5.1 (a 220.48% increase from previous year)
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Absci Corporation
Most recent Net Debt/EBITDAof ABSI including historical data for past 10 years.Interactive Chart of Net Debt/EBITDA of Absci Corporation
Absci Corporation Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 6.09 | 7.15 | 7.09 | – | – |
| 2022 | 9.58 | 7.58 | 8.16 | 9.41 | 1.79 |
| 2021 | 10.91 | 14.88 | -3.12 | 4.51 | 3.74 |
| 2020 | 14.49 | 0.0 | 0.0 | 0.0 | 5.1 |
| 2019 | 0.0 | – | – | – | 1.59 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology